NCT01303185

Brief Summary

The treatment options for nail psoriasis have been limited, and the management of nail psoriasis has been challenging for physicians.To evaluate the effect of pulsed dye laser (PDL) in the treatment of nail psoriasis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 24, 2011

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

December 12, 2014

Status Verified

December 1, 2014

Enrollment Period

1.1 years

First QC Date

February 22, 2011

Last Update Submit

December 11, 2014

Conditions

Psoriatic Nail

Keywords

Psoriatic NailPulsed dye laser

Outcome Measures

Primary Outcomes (2)

  • NAPSI

    3rd and 6th months

  • global physician assessment

    3rd and 6th months

Study Arms (2)

Experimental Group

Control Group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Psoriatic nail patients

You may qualify if:

  • Psoriatic nail refractory to other topical and systemic treatment therapy
  • ≧ 16 years old

You may not qualify if:

  • Patient with pregnancy
  • Patient with photo sensitivity
  • Patient with severe wound around finger nails or paronychia
  • Patient with hypersensitivity to Tazarotene cream

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University - WanFang Hospital

Taipei, Taiwan

Location

Study Officials

  • Ying-Yi Chiang

    Taipei Medical University WanFang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician

Study Record Dates

First Submitted

February 22, 2011

First Posted

February 24, 2011

Study Start

January 1, 2011

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

December 12, 2014

Record last verified: 2014-12

Locations

TW(1)